✦ LIBER ✦

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

✍ Scribed by Elisabeth Quoix; Rodryg Ramlau; Virginie Westeel; Zsolt Papai; Anne Madroszyk; Alain Riviere; Piotr Koralewski; Jean-Luc Breton; Erich Stoelben; Denis Braun; Didier Debieuvre; Hervé Lena; Marc Buyse; Marie-Pierre Chenard; Bruce Acres; Gisèle Lacoste; Bérangère Bastien; Annette Tavernaro; Nadine Bizouarne; Jean-Yves Bonnefoy; Jean-Marc Limacher

Book ID: 117785795
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 219 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70259-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine as first-lin

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 144 KB

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Phase III trial of docetaxel (D) and car

Phase III trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Giannakakis, Th; Mavroudis, D; Papadouris, S; Kourousis, Ch; Ziras, N; Kakolyris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Front-line paclitaxel and topotecan chem

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial

✍ G. P. Stathopoulos; C. Katis; D. Tsavdaridis; J. Dimitroulis; D. Karaindros; J. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 217 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB